Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
J Appl Physiol, 102(3):1065-70
Increased government focus on diabetes management programs and rising investments from global pharma players are accelerating adoption in the region
Identity and Contact Information of the Data Controller This privacy policy applies to all personal data processed by Sensilab d.o.o., with its registered office at Verovkova 55a, 1000 Ljubljana, Slovenia, , company registration number 2113732000, and Vision Healthcare Group, with its registered office at Grote Markt 41, 8500 Kortrijk, Belgium, company registration number BE 0685.849.188, acting as joint controllers under the GDPR (hereafter called 'Data Controller')
Reactive oxygen species: from tumorigenesis to therapeutic strategies in cancer
US$ 27.72
US$ 27.75
US$ 28.17
